Spire Wealth Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$48.7K	Hold	17,767	–	–	﹤0.01%	1174
2025 Q4	$65.7K	Hold	17,767	–	–	﹤0.01%	1099
2025 Q3	$47.1K	Sell	17,767 -80	-0.4%	-$155	﹤0.01%	1255
2025 Q2	$17.5K	Buy	17,847 +80	+0.5%	+$80	﹤0.01%	1557
2025 Q1	$25.6K	Hold	17,767	–	–	﹤0.01%	1519
2024 Q4	$39.1K	Hold	17,767	–	–	﹤0.01%	1375
2024 Q3	$29.3K	Hold	17,767	–	–	﹤0.01%	1316
2024 Q2	$39.4K	Hold	17,767	–	–	﹤0.01%	1202
2024 Q1	$47.6K	Hold	17,767	–	–	﹤0.01%	1232
2023 Q4	$35.9K	Buy	17,767 +7,267	+69%	+$9.43K	﹤0.01%	1316
2023 Q3	$10.3K	Hold	10,500	–	–	﹤0.01%	1724
2023 Q2	$14.6K	Hold	10,500	–	–	﹤0.01%	1703
2023 Q1	$16.7K	Buy	10,500 +386	+4%	+$1.99K	﹤0.01%	1683
2022 Q4	$63K	Hold	10,114	–	–	﹤0.01%	907
2022 Q3	$68K	Hold	10,114	–	–	﹤0.01%	845
2022 Q2	$64K	Hold	10,114	–	–	﹤0.01%	1194
2022 Q1	$47K	Hold	10,114	–	–	﹤0.01%	1469
2021 Q4	$51K	Buy	+10,114	New	+$81K	﹤0.01%	1715
2021 Q3	–	Sell	-100	Closed	-$2K	–	2588
2021 Q2	$2K	Hold	100	–	–	﹤0.01%	2475
2021 Q1	$3K	Buy	+100	New	+$2.95K	﹤0.01%	2744